Long-term methotrexate therapy may be discontinued in stable RA patients
02 Sep 2020
byJairia Dela Cruz
More than half of rheumatoid arthritis (RA) patients achieving low disease activity on long-term methotrexate (MTX) remain flare-free following its withdrawal, as shown in a study. The use of a higher MTX dose to preserve low disease activity is predictive of disease flare after discontinuation.
